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Commentary re: Considerations about TASC II: Is it a Suitable
Document for Specialists?
L. Norgren,1* and W.R. Hiatt2 On behalf of the TASC II Working Group
1University Hospital Orebro, Department of Surgery, S-701 85 Orebro, Sweden, and
2University of Colorado, Denver CO, USAThe editors of TASC II thank Dr. Pedrini for his
thoughtful comments on the TASC II document.1
One of the primary goals of TASC II was to stimulate
discussion, particularly at the National level, that will
keep TASC a living document. His careful reading of
the document has identified two referencing errors in
the Technical Section F, that unfortunately were not
picked up prior to press. We apologize for this mis-
take. Table F7a is incorrectly referenced to a meta-
analysis of the aortic bifurcation grafts2 instead of
a somewhat earlier article by the same lead author
comparing percutaneous and surgical revasculariza-
tion of the femoral popliteal segment.3 Reference 209
(Klinkert)4 refers to a paper by the same author in
the same year published in another journal.5
The TASC II document was primarily designed to
provide guidance for primary health physicians,
who should find an abbreviated, easy to read docu-
ment without too many technical details or references.
The editors also wanted to update information for
vascular specialists. However the ongoing debate of
the role of prosthetic versus vein grafts is an example
of how national vascular societies can get involved to
incorporate the general TASC II recommendations
into local practice. Such issues as well as the important
question when to use endovascular procedures versus
open surgery, were intentionally only briefly ad-
dressed in consensus between all 16 societies that
were involved in the writing process of TASC II.
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dissemination phase following publication. We will
be encouraging interested vascular specialists, as ex-
emplified by Dr. Pedrini, to become involved in this
phase by responding and working on local updates
that can be published in national journals. We hope
this process will bring up controversial issues for dis-
cussion, and when appropriate publish summarized
amendments.
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